Trial
NCT04097821
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Myelofibrosis
Intervention
Ruxolitinib
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-07